GENEVA — Alcon announced that Pataday Once Daily Relief Extra Strength (olopatadine hydrochloride ophthalmic solution 0.7%) is now available in-store and online at U.S. retailers, following its 2020 approval by the Food and Drug Administration (FDA) for sale over-the-counter (O-T-C). As Alcon’s third Rx-to-OTC switch in the past twelve months, Pataday Once Daily Relief Extra Strength
GENEVA – Alcon announced Tuesday that Pataday Once Daily Relief Extra Strength (olopatadine hydrochloride ophthalmic solution 0.7%), formerly prescribed as Pazeo, has been approved by the Food and Drug Administration (FDA) for sale over-the-counter (O-T-C) in the United States. Pataday Once Daily Relief Extra Strength is the first and only once daily eye allergy itch
FORT WORTH — Alcon announced that Pataday Once Daily Relief (olopatadine hydrochloride ophthalmic solution 0.2%) and Pataday Twice Daily Relief (olopatadine hydrochloride ophthalmic solution 0.1%) have been approved by the Food and Drug Administration (FDA) for sale over-the-counter (O-T-C) in the U.S. The Pataday brand features the No. 1 doctor-prescribed eye allergy itch relief ingredient,
FORT WORTH — Alcon, a division of Novartis, is inviting consumers to change their eye color as part of the AIR OPTIX Colors contact lenses sweepstakes for a chance to go backstage at New York Fashion Week: The Shows in February 2019. To enter, people must wear or virtually try on one of 12 colors
